2021
DOI: 10.21203/rs.3.rs-140205/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Genetic Polymorphisms, LDL-C and sdLDL-C Help Optimize Coronary Heart Disease (CHD) Therapy

Abstract: Background: Low-density lipoprotein cholesterol (LDL-C) and small, dense LDL-C (sdLDL-C) are important risk indicator of coronary heart disease (CHD), but their application in therapy monitoring of CHD is still far from being elucidated. Following the concept of precision medicine, we investigated whether the scientific medication based on medication-sensitive genes can reverse the LDL-C and sdLDL-C status in human bloodstream, so as to reveal the possibility of them as a monitoring indicator of CHD efficacy.M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Males with mild CHD, had concentrations of 28.9 mg/dL when compared to 39.9 mg/dL for individuals with acute CHD. Recently several genotypes have been associated with the different LDL-C subfractions (Dai et al, 2021).The relationship between sdLDL and ASCVD could have several underlying mechanisms. For example, sdLDL have an increased residence time compared to larger LDL-C (Thongtang et al, 2017).…”
Section: Novel Insights Into Atherosclerosismentioning
confidence: 99%
“…Males with mild CHD, had concentrations of 28.9 mg/dL when compared to 39.9 mg/dL for individuals with acute CHD. Recently several genotypes have been associated with the different LDL-C subfractions (Dai et al, 2021).The relationship between sdLDL and ASCVD could have several underlying mechanisms. For example, sdLDL have an increased residence time compared to larger LDL-C (Thongtang et al, 2017).…”
Section: Novel Insights Into Atherosclerosismentioning
confidence: 99%